免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

NovoSorb Matrix

K号: K221686 · 2022-09-15

决定日期2022-09-15
产品代码QSZ
决定实质等同

器械摘要

NovoSorb Matrix is the device name listed in this FDA 510(k) record. The listed applicant is Polynovo Biomaterials Pty, Ltd.. It received FDA 510(k) clearance on 2022-09-15 under 510(k) number K221686. The device is classified under product code QSZ. FDA Decision: Substantially Equivalent.

常见问题

What is the NovoSorb Matrix?

NovoSorb Matrix is a medical device that received FDA 510(k) clearance on 2022-09-15. The listed applicant is Polynovo Biomaterials Pty, Ltd.. The 510(k) number is K221686.

When did NovoSorb Matrix receive FDA 510(k) clearance?

NovoSorb Matrix received FDA 510(k) clearance on 2022-09-15, under 510(k) number K221686.

Who is the listed applicant for NovoSorb Matrix?

The FDA 510(k) record lists Polynovo Biomaterials Pty, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NovoSorb Matrix?

The FDA product code for NovoSorb Matrix is QSZ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Polynovo Biomaterials Pty, Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:QSZ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑